Persistent hypersplenism early after liver transplant: the role of splenectomy

Transplantation. 1997 Nov 27;64(10):1481-3. doi: 10.1097/00007890-199711270-00020.

Abstract

Background: Transient thrombocytopenia is common after liver transplantation, but persisting thrombocytopenia worsens the prognosis after transplant.

Methods: Two patients underwent splenectomy for persistent thrombocytopenia early after liver transplantation. The first patient had a platelet count of 17,000/mm3 on postoperative day (POD) 6; her hemoglobin and white blood cell counts were normal. Work-ups including bone marrow aspiration, Coombs test, and antiplatelet antibody test were negative. On POD 9, she had abdominal bleeding with a platelet count of 17,000/mm3 despite repeated platelet transfusions, and splenectomy was done. The second patient had a platelet count of 3000/mm3 on POD 14, white blood cell was 1600/mm3, and hemoglobin was 7.7 g/dl. Bone marrow biopsy revealed hypercellular marrow. Because his platelet count remained at 2000/mm3 despite empiric treatment with intravenous immune globulin and methylprednisolone, splenectomy was performed.

Results: The first patient's platelet count rose to 155,000/mm3 by POD 8. The second patient's platelet count reached 210,000/mm3 on POD 5. Neither patient has had an episode of thrombocytopenia at 36 and 32 months after splenectomy.

Conclusions: Splenectomy can be used after liver transplantation for severe, persistent thrombocytopenic states that cannot be attributed to sepsis, intravascular coagulation, immunological causes, or drug effects.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Female
  • Humans
  • Hypersplenism / complications*
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Splenectomy
  • Thrombocytopenia / etiology
  • Thrombocytopenia / surgery
  • Time Factors